JOHNSON INVESTMENT COUNSEL INC – Vertex Pharmaceuticals Incorporated Transaction History
JOHNSON INVESTMENT COUNSEL INC portfolio value:
$2.67M
portfolio value
JOHNSON INVESTMENT COUNSEL INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.79% | -568 shares | -89K | $289.54 | 9.24K |
| Q2 2022 | share | Decrease | -2.40% | -241 shares | 142K | $281.79 | 9.80K |
| Q1 2022 | share | Increase | +18.85% | 1.59K shares | 765K | $260.97 | 10.04K |
| Q4 2021 | share | Decrease | -5.67% | -508 shares | 231K | $222.45 | 8.45K |
| Q3 2021 | share | Decrease | -1.74% | -159 shares | -213K | $181.39 | 8.96K |
| Q2 2021 | share | Increase | +0.81% | 73 shares | -106K | $201.63 | 9.12K |
| Q1 2021 | share | Decrease | -0.14% | -13 shares | -197K | $214.89 | 9.04K |
| Q4 2020 | share | Increase | +0.71% | 64 shares | -307K | $236.34 | 9.06K |
| Q3 2020 | share | Increase | +0.07% | 6 shares | -161K | $272.12 | 8.99K |
| Q2 2020 | share | Decrease | -3.80% | -355 shares | 386K | $290.31 | 8.99K |
| Q1 2020 | share | Decrease | -0.67% | -63 shares | 164K | $237.95 | 9.34K |
| Q4 2019 | share | Decrease | -3.74% | -366 shares | 404K | $218.95 | 9.41K |
| Q3 2019 | share | Decrease | -3.34% | -338 shares | -198K | $169.42 | 9.77K |
| Q2 2019 | share | Increase | +2.45% | 242 shares | 39K | $183.38 | 10.11K |
| Q1 2019 | share | Decrease | -1.59% | -160 shares | 153K | $183.95 | 9.87K |
| Q4 2018 | share | Decrease | -1.12% | -114 shares | -293K | $165.71 | 10.03K |
| Q3 2018 | share | Decrease | -1.46% | -150 shares | 206K | $192.74 | 10.14K |
| Q2 2018 | share | Decrease | -0.16% | -16 shares | 69K | $169.96 | 10.29K |
| Q1 2018 | share | Increase | +0.44% | 45 shares | 142K | $162.98 | 10.31K |
| Q4 2017 | share | Decrease | -1.64% | -171 shares | -48K | $149.86 | 10.26K |
| Q3 2017 | share | Decrease | -22.46% | -3.02K shares | -148K | $152.04 | 10.43K |
| Q2 2017 | share | Decrease | -11.28% | -1.71K shares | 75K | $128.87 | 13.46K |
| Q1 2017 | share | Decrease | -23.48% | -4.65K shares | 199K | $109.35 | 15.17K |
| Q4 2016 | share | Decrease | -23.84% | -6.20K shares | -810K | $73.67 | 19.83K |
| Q3 2016 | share | Decrease | -9.95% | -2.87K shares | -217K | $87.21 | 26.03K |
| Q2 2016 | share | Decrease | -9.66% | -3.09K shares | -56K | $86.02 | 28.91K |
| Q1 2016 | share | Decrease | -2.63% | -865 shares | -1.59M | $79.49 | 32.00K |